Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 128 Pages
Report ld: 6896690
Request Sample
Customized Report
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Common side effects include dizziness, headache, bruising, allergic reactions, heartburn, and stomach pain. Severe side effects include an increased risk of heart disease, stroke, gastrointestinal bleeding, and stomach ulcers. The heart disease risk may be lower than with other NSAIDs. It is not recommended in people with kidney problems. Use is not recommended in the third trimester of pregnancy.
Naproxen is a nonselective COX inhibitor. It is in the propionic acid class of medications. As an NSAID, naproxen appears to exert its anti-inflammatory action by reducing the production of inflammatory mediators called prostaglandins. It is metabolized by the liver to inactive metabolites.
Naproxen was patented in 1967, and approved for medical use in the United States in 1976. It is available over the counter and as a generic medication. In 2017, it was the 71st most commonly prescribed medication in the United States, with more than eleven million prescriptions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Naproxen Active Pharmaceutical Ingredients, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Naproxen Active Pharmaceutical Ingredients market size, estimations, and forecasts are presented in terms of sales volume (Kiloton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Naproxen Active Pharmaceutical Ingredients.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Naproxen Active Pharmaceutical Ingredients manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Naproxen Active Pharmaceutical Ingredients sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Naproxen Active Pharmaceutical Ingredients sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Naproxen Active Pharmaceutical Ingredients Product Introduction
1.2 Global Naproxen Active Pharmaceutical Ingredients Market Size Forecast
1.2.1 Global Naproxen Active Pharmaceutical Ingredients Sales Value (2021–2032)
1.2.2 Global Naproxen Active Pharmaceutical Ingredients Sales Volume (2021–2032)
1.2.3 Global Naproxen Active Pharmaceutical Ingredients Sales Price (2021–2032)
1.3 Naproxen Active Pharmaceutical Ingredients Market Trends & Drivers
1.3.1 Naproxen Active Pharmaceutical Ingredients Industry Trends
1.3.2 Naproxen Active Pharmaceutical Ingredients Market Drivers & Opportunities
1.3.3 Naproxen Active Pharmaceutical Ingredients Market Challenges
1.3.4 Naproxen Active Pharmaceutical Ingredients Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Naproxen Active Pharmaceutical Ingredients Players Revenue Ranking (2025)
2.2 Global Naproxen Active Pharmaceutical Ingredients Revenue by Company (2021–2026)
2.3 Global Naproxen Active Pharmaceutical Ingredients Sales Volume Ranking of Players (2025)
2.4 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Company (2021–2026)
2.5 Global Naproxen Active Pharmaceutical Ingredients Average Price by Company (2021–2026)
2.6 Key Manufacturers Naproxen Active Pharmaceutical Ingredients Manufacturing Base and Headquarters
2.7 Key Manufacturers Naproxen Active Pharmaceutical Ingredients Product Offerings
2.8 Key Manufacturers Start of Mass Production of Naproxen Active Pharmaceutical Ingredients
2.9 Naproxen Active Pharmaceutical Ingredients Market Competitive Analysis
2.9.1 Naproxen Active Pharmaceutical Ingredients Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Naproxen Active Pharmaceutical Ingredients Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Naproxen Active Pharmaceutical Ingredients revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Naproxen Active Pharmaceutical Ingredients Market Classification
3.1 Introduction by Type
3.1.1 Purity (99%-99.5%)
3.1.2 Purity (above 99.5%)
3.1.3 Purity (below 99 %)
3.1.4 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Type
3.1.4.1 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Naproxen Active Pharmaceutical Ingredients Sales Value, by Type (2021–2032)
3.1.4.3 Global Naproxen Active Pharmaceutical Ingredients Sales Value, by Type (%), 2021–2032
3.1.5 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Type
3.1.5.1 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Naproxen Active Pharmaceutical Ingredients Sales Volume, by Type (2021–2032)
3.1.5.3 Global Naproxen Active Pharmaceutical Ingredients Sales Volume, by Type (%), 2021–2032
3.1.6 Global Naproxen Active Pharmaceutical Ingredients Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Treat pain
4.1.2 Menstrual cramps
4.1.3 Inflammatory diseases
4.1.4 Fever
4.1.5 Others
4.2 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Application
4.2.1 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Naproxen Active Pharmaceutical Ingredients Sales Value, by Application (2021–2032)
4.2.3 Global Naproxen Active Pharmaceutical Ingredients Sales Value, by Application (%), 2021–2032
4.3 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Application
4.3.1 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Naproxen Active Pharmaceutical Ingredients Sales Volume, by Application (2021–2032)
4.3.3 Global Naproxen Active Pharmaceutical Ingredients Sales Volume, by Application (%), 2021–2032
4.4 Global Naproxen Active Pharmaceutical Ingredients Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Region
5.1.1 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Region (2021–2026)
5.1.3 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Region (2027–2032)
5.1.4 Global Naproxen Active Pharmaceutical Ingredients Sales Value by Region (%), 2021–2032
5.2 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Region
5.2.1 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Region (2021–2026)
5.2.3 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Region (2027–2032)
5.2.4 Global Naproxen Active Pharmaceutical Ingredients Sales Volume by Region (%), 2021–2032
5.3 Global Naproxen Active Pharmaceutical Ingredients Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
5.4.2 North America Naproxen Active Pharmaceutical Ingredients Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
5.5.2 Europe Naproxen Active Pharmaceutical Ingredients Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
5.6.2 Asia Pacific Naproxen Active Pharmaceutical Ingredients Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
5.7.2 South America Naproxen Active Pharmaceutical Ingredients Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
5.8.2 Middle East & Africa Naproxen Active Pharmaceutical Ingredients Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Naproxen Active Pharmaceutical Ingredients Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Naproxen Active Pharmaceutical Ingredients Sales Value and Sales Volume
6.2.1 Key Countries/Regions Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.2.2 Key Countries/Regions Naproxen Active Pharmaceutical Ingredients Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.3.2 United States Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.4.2 Europe Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.5.2 China Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.5.3 China Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.6.2 Japan Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.7.2 South Korea Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.8.2 Southeast Asia Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Naproxen Active Pharmaceutical Ingredients Sales Value, 2021–2032
6.9.2 India Naproxen Active Pharmaceutical Ingredients Sales Value by Type (%), 2025 vs 2032
6.9.3 India Naproxen Active Pharmaceutical Ingredients Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Xinhua Pharm
7.1.1 Xinhua Pharm Company Information
7.1.2 Xinhua Pharm Introduction and Business Overview
7.1.3 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Product Offerings
7.1.5 Xinhua Pharm Recent Developments
7.2 Granules India Limited
7.2.1 Granules India Limited Company Information
7.2.2 Granules India Limited Introduction and Business Overview
7.2.3 Granules India Limited Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Granules India Limited Naproxen Active Pharmaceutical Ingredients Product Offerings
7.2.5 Granules India Limited Recent Developments
7.3 Huagang Pharm
7.3.1 Huagang Pharm Company Information
7.3.2 Huagang Pharm Introduction and Business Overview
7.3.3 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Product Offerings
7.3.5 Huagang Pharm Recent Developments
7.4 Hebei Jiheng Pharmaceutical
7.4.1 Hebei Jiheng Pharmaceutical Company Information
7.4.2 Hebei Jiheng Pharmaceutical Introduction and Business Overview
7.4.3 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Product Offerings
7.4.5 Hebei Jiheng Pharmaceutical Recent Developments
7.5 The Perrigo Company
7.5.1 The Perrigo Company Company Information
7.5.2 The Perrigo Company Introduction and Business Overview
7.5.3 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Product Offerings
7.5.5 The Perrigo Company Recent Developments
7.6 Taj Pharmaceuticals Ltd
7.6.1 Taj Pharmaceuticals Ltd Company Information
7.6.2 Taj Pharmaceuticals Ltd Introduction and Business Overview
7.6.3 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Product Offerings
7.6.5 Taj Pharmaceuticals Ltd Recent Developments
7.7 LGM Pharma
7.7.1 LGM Pharma Company Information
7.7.2 LGM Pharma Introduction and Business Overview
7.7.3 LGM Pharma Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 LGM Pharma Naproxen Active Pharmaceutical Ingredients Product Offerings
7.7.5 LGM Pharma Recent Developments
7.8 Iwaki Seiyaku
7.8.1 Iwaki Seiyaku Company Information
7.8.2 Iwaki Seiyaku Introduction and Business Overview
7.8.3 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Product Offerings
7.8.5 Iwaki Seiyaku Recent Developments
7.9 Atom pharma
7.9.1 Atom pharma Company Information
7.9.2 Atom pharma Introduction and Business Overview
7.9.3 Atom pharma Naproxen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Atom pharma Naproxen Active Pharmaceutical Ingredients Product Offerings
7.9.5 Atom pharma Recent Developments
8 Industry Chain Analysis
8.1 Naproxen Active Pharmaceutical Ingredients Industrial Chain
8.2 Naproxen Active Pharmaceutical Ingredients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Naproxen Active Pharmaceutical Ingredients Sales Model
8.5.2 Sales Channels
8.5.3 Naproxen Active Pharmaceutical Ingredients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Naproxen Active Pharmaceutical Ingredients market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 130
USD 2900.00
(Single User License)
The global Naproxen Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 147
USD 4900.00
(Single User License)
The global market for Naproxen Active Pharmaceutical Ingredients was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 110
USD 3950.00
(Single User License)
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published Date: 2024-04-16
Pages: 89
USD 4900.00
(Single User License)
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published Date: 2024-02-21
Pages: 100
USD 3950.00
(Single User License)
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published Date: 2024-01-08
Pages: 85
USD 2900.00
(Single User License)
The global Naproxen Active Pharmaceutical Ingredients market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 130
The global Naproxen Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 147
The global market for Naproxen Active Pharmaceutical Ingredients was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 110
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published: 2024-04-16
Pages: 89
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published: 2024-02-21
Pages: 100
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published: 2024-01-08
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now